609 related articles for article (PubMed ID: 37488757)
1. The Metabolic Basis for Nervous System Dysfunction in Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
Maiese K
Curr Neurovasc Res; 2023; 20(3):314-333. PubMed ID: 37488757
[TBL] [Abstract][Full Text] [Related]
2. Cellular Metabolism: A Fundamental Component of Degeneration in the Nervous System.
Maiese K
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238686
[TBL] [Abstract][Full Text] [Related]
3. Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.
Maiese K
Curr Neurovasc Res; 2017; 14(3):299-304. PubMed ID: 28721811
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of metabolic flexibility: The impact of mTOR on autophagy in neurodegenerative disease.
Maiese K
Int Rev Neurobiol; 2020; 155():1-35. PubMed ID: 32854851
[TBL] [Abstract][Full Text] [Related]
5. The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk.
Maiese K
Front Immunol; 2023; 14():1273570. PubMed ID: 38022638
[TBL] [Abstract][Full Text] [Related]
6. Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.
Maiese K
Br J Clin Pharmacol; 2016 Nov; 82(5):1245-1266. PubMed ID: 26469771
[TBL] [Abstract][Full Text] [Related]
7. The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.
Maiese K
Biochem Soc Trans; 2018 Apr; 46(2):351-360. PubMed ID: 29523769
[TBL] [Abstract][Full Text] [Related]
8. Warming Up to New Possibilities with the Capsaicin Receptor TRPV1: mTOR, AMPK, and Erythropoietin.
Maiese K
Curr Neurovasc Res; 2017; 14(2):184-189. PubMed ID: 28294062
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide: Oversight of Metabolic Dysfunction Through SIRT1, mTOR, and Clock Genes.
Maiese K
Curr Neurovasc Res; 2020; 17(5):765-783. PubMed ID: 33183203
[TBL] [Abstract][Full Text] [Related]
10. Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin.
Chong ZZ; Shang YC; Wang S; Maiese K
Prog Neurobiol; 2012 Nov; 99(2):128-48. PubMed ID: 22980037
[TBL] [Abstract][Full Text] [Related]
11. mTOR: on target for novel therapeutic strategies in the nervous system.
Maiese K; Chong ZZ; Shang YC; Wang S
Trends Mol Med; 2013 Jan; 19(1):51-60. PubMed ID: 23265840
[TBL] [Abstract][Full Text] [Related]
12. Oxidant stress and signal transduction in the nervous system with the PI 3-K, Akt, and mTOR cascade.
Maiese K; Chong ZZ; Wang S; Shang YC
Int J Mol Sci; 2012 Oct; 13(11):13830-66. PubMed ID: 23203037
[TBL] [Abstract][Full Text] [Related]
13. New Insights for nicotinamide: Metabolic disease, autophagy, and mTOR.
Maiese K
Front Biosci (Landmark Ed); 2020 Jun; 25(11):1925-1973. PubMed ID: 32472766
[TBL] [Abstract][Full Text] [Related]
14. Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathways.
Maiese K
Expert Rev Clin Pharmacol; 2020 Jan; 13(1):23-34. PubMed ID: 31794280
[No Abstract] [Full Text] [Related]
15. Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration.
Querfurth H; Lee HK
Mol Neurodegener; 2021 Jul; 16(1):44. PubMed ID: 34215308
[TBL] [Abstract][Full Text] [Related]
16. Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR.
Maiese K
Neural Regen Res; 2016 Mar; 11(3):372-85. PubMed ID: 27127460
[TBL] [Abstract][Full Text] [Related]
17. Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders.
Chong ZZ; Shang YC; Zhang L; Wang S; Maiese K
Oxid Med Cell Longev; 2010; 3(6):374-91. PubMed ID: 21307646
[TBL] [Abstract][Full Text] [Related]
18. Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.
Maiese K
Curr Neurovasc Res; 2018; 15(1):81-91. PubMed ID: 29557749
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin: new directions for the nervous system.
Maiese K; Chong ZZ; Shang YC; Wang S
Int J Mol Sci; 2012; 13(9):11102-11129. PubMed ID: 23109841
[TBL] [Abstract][Full Text] [Related]
20. Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders.
Cai H; Cong WN; Ji S; Rothman S; Maudsley S; Martin B
Curr Alzheimer Res; 2012 Jan; 9(1):5-17. PubMed ID: 22329649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
